A Patient with 38 Years of Smoking History and Severe Shortness of Breath

Author:

Buklis E. R.1ORCID,Kokina N. I.1ORCID,Bueverova E. L.1ORCID,Feldsherov M. V.1ORCID,Komarova V. S.2ORCID,Ivashkin V. T.1ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University (Sechenov University)

2. Polyclinic No. 7 of the Federal Security Service of the Russian Federation

Abstract

Aim: to present a clinical case of post-COVID bronchiolitis in an adult.Key points. A 54-year-old female patient with a long history of smoking was hospitalized in the pulmonology department of the Clinic with a leading complaint of progressive shortness of breath after a COVID-19 infection. The diagnosis was established: bilateral bronchiolitis associated with a new coronavirus infection (SARS-CoV-2 polymerase chain reaction — positive); chronic obstructive pulmonary disease stage II according to GOLD (Global Initiative for Chronic Obstructive Lung Disease), exacerbation. Against the background of the therapy, there was a significant positive dynamics in well-being and in CT-picture of bronchiolitis. The patient was discharged for outpatient follow-up treatment. One of the most common symptoms of post-COVID syndrome is shortness of breath. Diagnosis of bronchiolitis, in which this symptom may be the only one, is difficult, especially in patients with a long history of smoking and the presence of comorbid pulmonary pathology.Conclusion. A clinical case of bilateral bronchiolitis in the framework of the post-COVID syndrome is presented. The key to successful diagnosis of bronchiolitis is a thorough differential analysis of the totality of anamnestic and clinical laboratory data, as well as a characteristic CT pattern.

Publisher

Russian Gastroenterolgocial Society

Subject

Gastroenterology,Hepatology,Surgery,Internal Medicine

Reference26 articles.

1. World Health Organization. Novel coronavirus (2019- nCoV) situation report 5. 25 January 2020 URL: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200125-sitrep-5-2019-ncov.pdf?sfvrsn=429b143d_8

2. Lenharo M. WHO declares end to COVID-19’s emergency phase. Nature. 2023 May 5. (Online ahead of print). DOI: 10.1038/d41586-023-01559-z

3. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): Temporary guidelines. Version 17, approved by the Ministry of Health of the Russian Federation December 14 2022. (In Russ.). URL: rosminzdrav. ru/ministry/med_covid19

4. World Health Organization. Coronavirus (COVID-19) Dashboard. Russian Federation. URL: https://covid19.who.int/region/euro/country/ru

5. Ivaschkin V.T., Zolnikova О.Yu., Svistunov A.A., Kokina N.I., Dzhakhaya N.L., Potskhverashvili N.D., et al. Corticosteroids in the treatment of SARS-CoV-2 related lung disease. Sechenov Medical Journal. 2020;11(2):19– 28. (In Russ.). DOI: 10.47093/2218-7332.2020.11.2.19-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3